Results 181 to 190 of about 10,579 (231)
Some of the next articles are maybe not open access.
Current Opinion in Otolaryngology & Head & Neck Surgery, 2008
Sublingual immunotherapy is an established treatment option for allergic rhinitis in many European countries, but it is not approved in the United States and is considered investigational. Sublingual immunotherapy has received increasing attention in the United States as an alternative to subcutaneous immunotherapy for the treatment of allergic ...
+6 more sources
Sublingual immunotherapy is an established treatment option for allergic rhinitis in many European countries, but it is not approved in the United States and is considered investigational. Sublingual immunotherapy has received increasing attention in the United States as an alternative to subcutaneous immunotherapy for the treatment of allergic ...
+6 more sources
Otolaryngologic Clinics of North America, 2011
Sublingual immunotherapy (SLIT) has been shown to be safe and efficacious in treating allergic rhinitis. It has been used in Europe for more than 20 years, and interest in the United States is increasing. SLIT has been shown to elicit immunologic changes similar to subcutaneous injection immunotherapy.
Sandra Y, Lin, Bryan, Leatherman
openaire +2 more sources
Sublingual immunotherapy (SLIT) has been shown to be safe and efficacious in treating allergic rhinitis. It has been used in Europe for more than 20 years, and interest in the United States is increasing. SLIT has been shown to elicit immunologic changes similar to subcutaneous injection immunotherapy.
Sandra Y, Lin, Bryan, Leatherman
openaire +2 more sources
Journal of Allergy and Clinical Immunology, 2001
Recent claims have been made that sublingual immunotherapy (SLIT) may be a viable alternative to injection immunotherapy (SIT). Animal studies show that when allergens are administered topically, they are handled differently, and IgE responses can be reduced.
Frew, Anthony J., Smith, Helen E.
openaire +3 more sources
Recent claims have been made that sublingual immunotherapy (SLIT) may be a viable alternative to injection immunotherapy (SIT). Animal studies show that when allergens are administered topically, they are handled differently, and IgE responses can be reduced.
Frew, Anthony J., Smith, Helen E.
openaire +3 more sources
Pediatric sublingual allergen immunotherapy
Allergy and Asthma Proceedings, 2022Sublingual immunotherapy (SLIT) offers an important therapeutic modality in the management of children with respiratory allergies. Along with subcutaneous immunotherapy, these modalities are the only selections that have shown not merely relief of symptoms but also disease-modifying activity.
openaire +2 more sources
Current Opinion in Allergy & Clinical Immunology, 2013
It is likely that approval of allergen preparations for sublingual immunotherapy (SLIT) will soon occur in the United States. This article reviews experience with SLIT in this country, concentrating on the large, multicenter trials that will provide the evidence of safety and efficacy necessary to obtain that approval.Large multicenter trials have been
openaire +2 more sources
It is likely that approval of allergen preparations for sublingual immunotherapy (SLIT) will soon occur in the United States. This article reviews experience with SLIT in this country, concentrating on the large, multicenter trials that will provide the evidence of safety and efficacy necessary to obtain that approval.Large multicenter trials have been
openaire +2 more sources
Sublingual and oral immunotherapy
Immunology and Allergy Clinics of North America, 2004Sublingual immunotherapy (SLIT) is a viable alternative to the subcutaneous route for the treatment of respiratory allergy, whereas the pure oral route has been abandoned because of its lack of efficacy. The main distinctive feature of SLIT is its optimal safety profile, which has been demonstrated in adults and children.
CANONICA, GIORGIO +3 more
openaire +2 more sources
Mechanisms of Sublingual Immunotherapy
Immunology and Allergy Clinics of North America, 2009Allergen-specific sublingual immunotherapy is now recognized to be an efficacious and well-tolerated treatment for allergic rhinitis. Emerging treatment strategies are also aimed at the primary treatment of allergic asthma, particularly allergy to house dust mites.
Guy, Scadding, Stephen R, Durham
openaire +3 more sources
Sublingual immunotherapy: an update
Current Opinion in Allergy and Clinical Immunology, 2004Sublingual immunotherapy is now officially accepted as a viable alternative to the traditional subcutaneous route, and it is widely used especially in European countries. Despite the large amount of experimental evidence on the safety and efficacy of the method, some concerns still exist, and several aspects need to be clarified: magnitude of the ...
PASSALACQUA, GIOVANNI +2 more
openaire +3 more sources
Sublingual specific immunotherapy.
Discovery medicine, 2010Sublingual application of allergen extracts in specific immunotherapy is a modern approach aimed at improving patient treatment acceptance through reduced serious side effects. This therapeutic approach has proven to be efficacious and safe for the treatment of allergies caused by airborne allergens: 1) studies have shown a rapid onset of action, as ...
Mösges R., El Hassan E., Passali D.
openaire +2 more sources
Emerging sublingual immunotherapy drugs
Expert Opinion on Pharmacotherapy, 2010There is epidemiological evidence that respiratory allergy has reached epidemic proportions; owing to the related socio-economic impact, this topic deserves particular attention. An integrated approach involving pharmacotherapy and the immunomodulatory effect of immunotherapy is expected to optimize the management of respiratory allergy, reducing its ...
Compalati E +4 more
openaire +3 more sources